AI Strategy & Technology Insights | Harry Glorikian

Skip to main content Scroll Top

By Harry Glorikian Publications

29 Jan: Exploring the Fascinating Intersection of Data and Biology: A Journey into Generative AI

NEW BOOK The Invisible Interface Harry Glorikian’s new book explores…

By Harry Glorikian Publications

22 Jan: Discover Tomorrow’s Leaders with The Harry Glorikian Show: A Nexus of Data, Biology, and Success

NEW BOOK The Invisible Interface Harry Glorikian’s new book explores…

By Harry Glorikian Blog

20 Jan: The Solo Billionaire: Unveiling the AI-Driven Future of Solo Entrepreneurship

NEW BOOK The Invisible Interface Harry Glorikian’s new book explores…

By Harry Glorikian Interview

17 Jan: Harry Glorikian on OTC Self-Tests

NEW BOOK The Invisible Interface Harry Glorikian’s new book explores…

By Harry Glorikian Publications

16 Jan: Embracing AI: Beyond Just Another Tool

NEW BOOK The Invisible Interface Harry Glorikian’s new book explores…

T Cell Engagers: The New Cancer Drug? (EP 130 - The Harry Glorikian Show)

By Harry Glorikian Podcasts

16 Jan: T Cell Engagers: The New Cancer Drug?

LabGenius CTO Leonard Wossnig on combining synthetic biology, high-throughput assays and machine learning to design T cell engagers, the next generation of antibody cancer drugs.

By Harry Glorikian Publications

10 Jan: OpenAI’s GPT Store Ignites the Next Step in the AI Revolution

NEW BOOK The Invisible Interface Harry Glorikian’s new book explores…

By Harry Glorikian Blog

29 Dec: Transforming Healthcare with Large Language Models (LLMs): Navigating the New Frontier with Optimism and the Right Level of Caution

NEW BOOK The Invisible Interface Harry Glorikian’s new book explores…

1 … 10 11 12 … 46